(Q40611412)

22 September 2017

Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell lines (English)

1 reference

22 September 2017

5

Paul Richardson

1 reference

22 September 2017

6

Kenneth Anderson

1 reference

22 September 2017

3

Dharminder Chauhan

1 reference

22 September 2017

1

Teru Hideshima

1 reference

22 September 2017

4

Masaharu Akiyama

1 reference

22 September 2017

Toshiaki Hayashi

2

1 reference

PubMed ID

14647474

22 September 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

22 September 2017

1 reference

22 September 2017

22

1 reference

22 September 2017

54

1 reference

22 September 2017

8797-8801

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206919

22 September 2017

0 references

cites work

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

JNK-dependent release of mitochondrial protein, Smac, during apoptosis in multiple myeloma (MM) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

JNK/SAPK activity contributes to TRAIL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

NF-kappa B as a therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

Integrating stress-response and cell-cycle checkpoint pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

The JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

c-Jun NH2-terminal Kinase Activation Leads to a FADD-dependent but Fas Ligand-independent Cell Death in Jurkat T Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

7 January 2021

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

7 January 2021

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

7 January 2021

Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

7 January 2021

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

7 January 2021

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206919

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206919

1 reference

PubMed ID

14647474

Dimensions Publication ID

22 September 2017

0 references

1 reference

PubMed ID

14647474